Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell wins DoxTek Training Excellence Award
Mitchell was recently recognized by its partner DoxTek with the Training Excellence Award at their event Connexion 2019.
Mitchell
News Release
Mitchell wins DoxTek Training Excellence Award
Mitchell was recently recognized by its partner DoxTek with the Training Excellence Award at
Workers' Comp
Article
MSA Self- Administration Toolkit
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
MSA Self- Administration Toolkit
Keep current with new legislation and its potential effect on your organization.
Mitchell
Conference
SEMA Show 2020
The SEMA Show is the premier automotive specialty products trade
Mitchell
Conference
IBIS Summit 2020
IBIS has built up an enviable reputation as a source of high-leve